Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aconite Pain Oil for the Prevention of Chemotherapy-induced Polyneuropathy
NCT06186479Phase 3Recruiting
- Sponsor
- WALA Heilmittel GmbH
- Start
- Mar 2024
- Primary completion
- Sep 2027
- Modality
- Botanical, Homeopathy, TCM (Traditional Chinese Medicine)
- Countries
- 1
01
Overview
A Phase 3 trial of Aconite in polyneuropathy, sponsored by WALA Heilmittel GmbH. Started Mar 2024; status: recruiting.
02
Drugs
Aconite
03
Conditions
polyneuropathy
Beyond the preview
Go deeper on NCT06186479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06186479.